Q1 2021 Holdings
Filed 2021-05-17 | 46 holdings | $478.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $254.9M | 925,500 | 53.2% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $124.6M | 1,650,000 | 26.0% |
| Acadia Pharmaceuticals Inc(ACAD) | Common | 004225108 | $64.5M | 2,500,000 | 13.5% |
| Adaptimmune Therapeutics PLC(ADAPY) | Sponsored ADR | 00653A107 | $18.9M | 3,550,000 | 3.9% |
| Black Diamond Therapeutics Inc(BDTX) | Common | 09203E105 | $10.7M | 440,000 | 2.2% |
| Horizon Therapeutics PLC | Common | G46188101 | $828.4K | 9,000,000 | 0.2% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $800.8K | 4,675,000 | 0.2% |
| United Therapeutics Corp(UTHR) | Common | 91307C102 | $501.8K | 3,000,000 | 0.1% |
| Acceleron Pharma Inc(XLRN) | Common | 00434H108 | $406.8K | 3,000,000 | 0.1% |
| Vertex Pharmaceuticals Inc(VRTX) | Common | 92532F100 | $300.8K | 1,400,000 | 0.1% |
| Arena Pharmaceuticals Inc(ARNAEUR) | Common | 040047607 | $281.0K | 4,050,000 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $253.3K | 8,000,000 | 0.1% |
| Ascendis Pharma | Sponsored ADR | 043351P10 | $244.9K | 1,900,000 | 0.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $166.7K | 1,425,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | Common | 803607100 | $160.2K | 2,150,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $121.0K | 12,250,000 | 0.0% |
| Kura Oncology Inc(KURA) | Common | 50127T109 | $113.1K | 4,000,000 | 0.0% |
| Mersana Therapeutics Inc | Common | 59045L106 | $110.0K | 6,800,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | Common | 00773U108 | $78.9K | 8,000,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | Common | 69353Y103 | $77.6K | 2,360,267 | 0.0% |
| Constellation Pharmaceuticals Inc(CNST) | Common | 210373106 | $69.0K | 2,950,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $65.3K | 3,650,000 | 0.0% |
| Trillium Therapeutics Inc | Common | 89620X506 | $61.2K | 5,700,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | Common | 87164F105 | $55.9K | 2,500,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | Common | 75955J402 | $53.7K | 1,525,000 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | Common | 56854Q200 | $50.1K | 3,235,000 | 0.0% |
| Praxis Precision Medicines Inc | Common | 74006W108 | $47.4K | 1,596,495 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $46.8K | 10,300,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | Common | 46583P102 | $44.8K | 7,250,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | Common | 03753U106 | $42.9K | 1,000,000 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | Common | 24344T101 | $40.0K | 893,000 | 0.0% |
| Design Therapeutics Inc(DSGN) | Common | 25056L103 | $39.7K | 1,468,318 | 0.0% |
| Avadel Pharmaceuticals PLC | Sponsored ADR | 05337M104 | $39.5K | 4,365,000 | 0.0% |
| Amarin Corp PLC | Sponsored ADR | 023111206 | $37.3K | 6,000,000 | 0.0% |
| Travere Therapeutics Inc(TVTX) | Common | 89422G107 | $31.2K | 1,249,000 | 0.0% |
| Mannkind Corp(MNKD) | Common | 56400P706 | $29.4K | 7,500,000 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $24.6K | 876,986 | 0.0% |
| Relay Therapeutics Inc(RLAY) | Common | 75943R102 | $17.3K | 500,000 | 0.0% |
| Merus N V | Common | N5749R100 | $13.9K | 665,000 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | Common | 372427401 | $13.8K | 5,084,184 | 0.0% |
| Avidity Biosciences Inc(RNA) | Common | 05370A108 | $11.9K | 545,000 | 0.0% |
| Therapeutics Acquisition Corp | Common | 88339T103 | $10.5K | 1,000,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $10.4K | 1,670,000 | 0.0% |
| Bctg Acquisition Corp | Common | 05492W103 | $8.9K | 800,000 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | Common | 481116101 | $5.7K | 555,000 | 0.0% |
| Galapagos NV(GLPG) | Sponsored ADR | 36315X101 | $239 | 3,100 | 0.0% |